Table 5. . Susceptibility pattern toward erythromycin and clindamycin.
| Resistant and susceptible phenotype | Erythromycin | Clindamycin | D-test | S. aureus no. (%) | MRSA no. (%) | MSSA no. (%) |
|---|---|---|---|---|---|---|
| iMLSB | R | S | D+ | 8 (15.4) | 6 (15.4) | 2 (15.4) |
| cMLSB | R | R | – | 7 (13.5) | 5 (12.8) | 2 (15.4) |
| MSB | R | S | D- | 17 (32.7) | 15 (38.5) | 4 (30.8) |
| Susceptible | S | S | – | 20 (38.5) | 13 (33.3) | 5 (38.5) |
| Total no. (%) | NA | NA | NA | 52 (100) | 39 (100) | 13 (100) |
ICR: Inducible clindamycin-resistant; MLSB: Macrolide-lincosamide-streptogramin B; cMLSB: Constitutive MLSB phenotype; iMLSB: Inducible iMLSB phenotype or ICR phenotypes; MSB: MSB phenotype; NA: Not applicable.